Topic: ACAD
Latest Valuation: ACADIA Pharmaceuticals (NASDAQ: ACAD)
ACADIA Pharmaceuticals trades as part of the biotechnology industry and is in the healthcare sector. The company CEO is Stephen R. Davis. ACADIA Pharmaceuticals Inc is a biotechnology company which develops and commercializes...










